Fidelity Investments
TLSI icon

Fidelity Investments’s TriSalus Life Sciences TLSI Stock Holding History

Fidelity Investments’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6K Buy
2,558
+1,242
+94% +$4.93K ﹤0.01% 4846
2026
Q1 		$5.26K Sell
1,316
-9,459
-88% -$46.3K ﹤0.01% 4906
2025
Q4 		$75.2K Buy
10,775
+10,519
+4,109% +$58.9K ﹤0.01% 3895
2025
Q3 		$1.19K Buy
+256
New +$1.2K ﹤0.01% 4999

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Fidelity Investments's TLSI Position: Q2 2026 in Review

Fidelity Investments increased its TriSalus Life Sciences (TLSI) stake by 94% in Q2 2026, buying an estimated $4.93K and bringing the position to 2,558 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4846.

Fidelity Investments first reported a position in TLSI in Q3 2025 and has held it in 4 quarters since. The position peaked at $75.2K in Q4 2025. 78 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • Fidelity Investments held 2,558 shares of TriSalus Life Sciences worth $11.6K as of Q2 2026.
  • Fidelity Investments bought 1,242 TriSalus Life Sciences shares in Q2 2026, an estimated $4.93K.
  • TriSalus Life Sciences made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4846 holding.
  • Fidelity Investments first reported a position in TriSalus Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • Fidelity Investments's TriSalus Life Sciences position peaked at $75.2K in Q4 2025.
  • 78 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.